Lv1
40 积分 2023-03-18 加入
From Breakthroughs to Blueprints: Evolving Evidence and Future Directions in Relapsed and Refractory Large B-Cell Lymphoma
7天前
已关闭
Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy
7天前
已完结
Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing–Neel Syndrome
21天前
已完结
Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis
22天前
已完结
The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease
28天前
已完结
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study
28天前
已完结
The Role of Meta-Epidemiology in Oncology Research—Bridging Evidence and Practice
1个月前
已完结
The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months
2个月前
已完结
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years
2个月前
已完结
How I treat secondary CNS involvement by aggressive lymphomas
2个月前
已完结
皖公网安备34019202002308
